Characterization of the ovalbumin-specific TCR transgenic line OT-I: MHC elements for positive and negative selection

Immunology and Cell Biology

Volumn 78, Issue 2, 2000, Pages 110-117

  Clarke, Sally RMcK ^a,b   Barnden, Megan ^c   Kurts, Christian ^a   Carbone, Francis R ^c   Miller, Jacques Fap ^a   Heath, William R ^a,d  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

CD8+ T lymphocyte; Cytotoxic T lymphocyte; Ovalbumin; Thymus; Transgenic T cell receptor

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; OVALBUMIN;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL PROLIFERATION; CELL SELECTION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; T LYMPHOCYTE SUBPOPULATION; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD4; ANTIGENS, CD8; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; FLOW CYTOMETRY; HAPLOTYPES; HISTOCOMPATIBILITY ANTIGENS CLASS I; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION; OVALBUMIN; RECEPTORS, ANTIGEN, T-CELL;

ANIMALIA; MUS MUSCULUS;

EID: 0034092544     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.2000.00889.x     Document Type: Article

References (31)

1. 1 McHeyzer-Williams MG, Davis MM. Antigen-specific development of primary and memory T cells in vivo. Science 1995; 268: 106-11.
2. 2 Altman JD, Moss PAH, Goulder DH et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 1996; 274: 94-6.
3. 3 Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone FR. T cell receptor antagonist peptides induce positive selection. Cell 1994; 76: 17-27.
4. 4 Ashton-Rickardt PG, Bandeira A, Delaney JR et al. Evidence for a differential avidity model of T cell selection in the thymus. Cell 1994; 76: 651-63.
5. + T cells. Immunity 1995; 3: 79-86.
6. 6 Sebzda E, Wallace VA, Mayer J, Yeung RSM, Mak TW, Ohashi PS. Positive and negative thymocyte selection induced by different concentrations of a single peptide. Science 1994; 263: 1615-18.
7. 7 Jameson SC, Hogquist KA, Bevan MJ. Specificity and flexibility in thymic selection. Nature 1994; 369: 750-2.
8. 8 Kelly JM, Sterry SJ, Cose SC et al. Identification of conserved T cell receptor CDR3 residues contacting known exposed peptide side chains from a major histocompatibility complex class I-bound determinant. Eur. J. Immunol. 1993; 23: 3318-26.
9. 9 Heath WR, Miller JFAP. Expression of two alpha chains by TCR transgenic T cells: demonstration and consequences. J. Exp. Med. 1993; 178: 1807-11.
10. + T lymphocytes. J. Immunol. 1993; 151: 5993-6001.
11. 11 Barnden MJ, Heath WR, Carbone FR. Down-modulation of CD8 β-chain in response to an altered peptide ligand enables developing thymocytes to escape negative selection. Cell. Immunol. 1997; 175: 111-19.
12. + T cell help. J. Exp. Med. 1997; 186: 65-70.
13. ht thymocytes. J. Exp. Med. 1995; 181: 1643-51.
14. + T cell pools. Eur. J. Immunol. 1995; 25: 2127-36.
15. 15 Nathenson SG, Geliebter J, Pfaffenbach GM, Zeff RA. Murine major histocompatibility complex class-I mutants: Molecular analysis and structure-function implications. Annu. Rev. Immunol. 1986; 4: 471-502.
16. 16 Borgulya P, Kishi H, Uematsu Y, von Boehmer H. Exclusion and inclusion of α and β T cell receptor alleles. Cell 1992; 69: 529-37.
17. 17 Berg LJ, Fazekas De St Groth B, Ivars F et al. Expression of T-cell receptor alpha-chain genes in transgenic mice. Mol. Cell. Biol. 1988; 8: 5459-69.
18. 18 Barnden MJ, Heath WR, Rodda S, Carbone FR. Peptide antagonists that promote positive selection are inefficient at T cell activation and thymocyte deletion. Eur. J. Immunol. 1994; 24: 2452-6.
19. 19 Blanas E, Carbone FR, Allison J, Miller JFAP, Heath WR. Oral administration of autoantigen can lead to the onset of autoimmune diabetes. Science 1996; 274: 1707-9.
20. 20 Hogquist KA, Tomlinson AJ, Kieper WC et al. Identification of a naturally occurring ligand for thymic positive selection. Immunity 1997; 6: 389-99.
21. 21 Kim SK, Reed DS, Heath WR, Carbone F, Lefrancoisa L. Activation and migration of CD8 T cells in the intestinal mucosa. J. Immunol. 1997; 159: 4295-306.
22. 22 Koniaras C, Bennett SRM, Carbone FR, Heath WR, Lew AM. Peptide induced deletion of CD8 T cells in vivo occurs via apoptosis in situ. Int. Immunol. 1997; 9: 1601-5.
23. + T cell tolerance by cross-presentation of self antigens. Immunol. Rev. 1998; 165: 267-77.
24. + T cells. J. Exp. Med. 1998; 188: 1977-83.
25. 25 Rolph MS, Matthaei KI, Carbone FR, Heath WR, Ramshaw IA. Loss of antiviral cytotoxic T-lymphocyte activity during high-level antigen stimulation. Viral Immunol. 1998; 11: 183-95.
26. 26 Kurts C, Carbone FR, Krummel MF, Koch KM, Miller JF, Heath WR. Signalling through CD30 protects against autoimmune diabetes mediated by CD8 T cells. Nature 1999; 398: 341-4.
27. 27 Morgan DJ, Kurts C, Kreuwel HT, Holst KL, Heath WR, Sherman LA. Ontogeny of T cell tolerance to peripherally expressed antigens. Proc. Natl Acad. Sci. USA 1999; 96: 3854-8.
28. 28 Lefrancois L, Parker CM, Olson S, Muller W, Wagner N, Puddington L. The role of beta7 integrins in CD8 T cell trafficking during an antiviral immune response. J. Exp. Med. 1999; 189: 1631-8.
29. + T cells: Efficacy is limited by migration away from the site and induction of nonresponsiveness. J. Immunol. 1999; 162: 2858-66.
30. 30 Daniels MA, Schober SL, Hogquist KA, Jameson SC. Cutting edge: A test of the dominant negative signal model for TCR antagonism. J. Immunol. 1999; 162: 3761-4.
31. + single positive cells with a class II major histocompatibility complex-restricted receptor. J. Exp. Med 1994; 180: 25-34.